Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017, Article ID 3197320, 11 pages
https://doi.org/10.1155/2017/3197320
Research Article

Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats

1Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China
2Department of Cardiology, People’s Hospital of Nanbu County, Nanchong, Sichuan, China
3Department of Cardiology, Shandong University, Jinan, Shandong, China

Correspondence should be addressed to Jingmin Zhou; nc.hs.latipsoh-sz@nimgnij.uohz

Received 18 January 2017; Revised 8 April 2017; Accepted 7 May 2017; Published 19 June 2017

Academic Editor: Giuseppe Caminiti

Copyright © 2017 Jingfeng Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Nishimura and W. Jaber, “Understanding 'diastolic heart failure': the tip of the iceberg,” Journal of the American College of Cardiology, vol. 49, no. 6, pp. 695–697, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Abbate, R. Arena, N. Abouzaki et al. et al., “Heart failure with preserved ejection fraction: refocusing on diastole,” International Journal of Cardiology, vol. 179, pp. 430–440, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. K. W. Kang, O. S. Kim, J. Y. Chin et al. et al., “Diastolic dysfunction induced by a high-fat diet is associated with mitochondrial abnormality and adenosine triphosphate levels in rats,” Endocrinology and Metabolism, vol. 30, no. 4, pp. 557–568, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Ren, L. Pulakat, A. Whaley-Connell, and J. R. Sowers, “Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease,” Journal of Molecular Medicine, vol. 88, no. 10, pp. 993–1001, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Mori, R. Basu, B. A. McLean et al. et al., “Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction,” Circulation Heart Failure, vol. 5, no. 4, pp. 493–503, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Dinh, M. Lankisch, W. Nickl et al. et al., “Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study,” Cardiovascular Diabetology, vol. 9, article 63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. S. Hamirani, B. K. Kundu, M. Zhong et al., “Noninvasive detection of early metabolic left ventricular remodeling in systemic hypertension,” Cardiology, vol. 133, no. 3, pp. 157–162, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Hermida, A. Markl, J. Hamelet et al. et al., “HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome,” Cardiovascular Research, vol. 99, no. 1, pp. 44–54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. J. Li, P. H. Wang, C. Chen, M. H. Zou, and D. W. Wang, “Improvement of mechanical heart function by trimetazidine in db/db mice,” Acta Pharmacologica Sinica, vol. 31, no. 5, pp. 560–569, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Li X, Zhang J, Huang J et al. et al., “A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure,” Journal of the American College of Cardiology, vol. 62, no. 12, pp. 1065–1072, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Tao, S. Shen, S. Fu et al., “Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice,” Scientific Reports, vol. 5, article 8374, 2015. View at Publisher · View at Google Scholar
  12. Y. Zou, L. Lin, Y. Ye et al., “Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice,” Journal of Cardiovascular Pharmacology, vol. 59, no. 3, pp. 268–280, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. F. Zhang, C. Wei, and H. T. Wang, “Protective effect of qiliqiangxin capsule on energy metabolism and myocardial mitochondria in pressure overload heart failure rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 378298, 9 pages, 2013. View at Publisher · View at Google Scholar
  14. S. Lin, X. Wu, L. Tao et al., “The metabolic effects of traditional Chinese medication qiliqiangxin on H9C2 cardiomyocytes,” Cellular Physiology and Biochemistry, vol. 37, no. 6, pp. 2246–2256, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. O. H. L. Bing, W. W. Brooks, K. G. Robinson et al., “The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure,” Journal of Molecular and Cellular Cardiology, vol. 27, no. 1, pp. 383–396, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. O. H. Cingolani, X.-P. Yang, M. A. Cavasin, and O. A. Carretero, “Increased systolic performance with diastolic dysfunction in adult spontaneously hypertensive rats,” Hypertension, vol. 41, no. 2, pp. 249–254, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. I. J. LeGrice, A. J. Pope, G. B. Sands, G. Whalley, R. N. Doughty, and B. H. Smaill, “Progression of myocardial remodeling and mechanical dysfunction in the spontaneously hypertensive rat,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 303, no. 11, pp. H1353–H1365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Fu, J. Zhou, J. Qian et al., “Adiponectin through its biphasic serum level is a useful biomarker during transition from diastolic dysfunction to systolic dysfunction - An experimental study,” Lipids in Health and Disease, vol. 11, article no. 106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Quintana-Villamandos, M. J. Delgado-Martos, C. Fernandez-Riveira et al., “Can 18F-FDG-PET show differences in myocardial metabolism between Wistar Kyoto rats and spontaneously hypertensive rats?” Laboratory Animals, vol. 47, no. 4, pp. 320–323, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. P. A. Watson, N. Birdsey, G. S. Huggins, E. Svensson, D. Heppe, and L. Knaub, “Cardiac-specific overexpression of dominant-negative CREB leads to increased mortality and mitochondrial dysfunction in female mice,” American Journal of Physiology - Heart and Circulatory Physiology, vol. 299, no. 6, pp. H2056–H2068, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. M. O. Boluyt, O. H. L. Bing, and E. G. Lakatta, “The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure,” European Heart Journal, vol. 16, pp. 19–30, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. S. W. Lee, E. Y. Choi, S. Y. Jung, S. T. Choi, S. K. Lee, and Y. B. Park, “E/E' ratio is more sensitive than E/A ratio for detection of left ventricular diastolic dysfunction in patients with systemic sclerosis,” Clinical and Experimental Rheumatology, vol. 28, Supplement 58, no. 2, pp. S12–S17, 2010. View at Google Scholar
  23. M. Fu, J. Zhou, J. Xu et al., “Olmesartan attenuates cardiac hypertrophy and improves cardiac diastolic function in spontaneously hypertensive rats through inhibition of calcineurin pathway,” Journal of Cardiovascular Pharmacology, vol. 63, no. 3, pp. 218–226, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Díez, A. González, B. López, and R. Querejeta, “Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease,” Nature Clinical Practice Cardiovascular Medicine, vol. 2, no. 4, pp. 209–216, 2005. View at Publisher · View at Google Scholar
  25. A. Garnier, D. Fortin, C. Deloménie, I. Momken, V. Veksler, and R. Ventura-Clapier, “Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles,” The Journal of Physiology, vol. 551, no. 2, pp. 491–501, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Tang, C. Mi, J. Liu, F. Gao, and J. Long, “Compromised mitochondrial remodeling in compensatory hypertrophied myocardium of spontaneously hypertensive rat,” Cardiovascular Pathology, vol. 23, no. 2, pp. 101–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Li, X. Hu, P. Selvakumar et al., “Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle,” American Journal of Physiology - Endocrinology and Metabolism, vol. 287, no. 5, pp. E834–E841, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Paternostro, K. Clarke, J. Heath, L. S. Anne-Marie, L. Seymour, and G. K. Radda, “Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart,” Cardiovascular Research, vol. 30, no. 2, pp. 205–211, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Linz, M. Hohl, F. Mahfoud et al., “Cardiac remodeling and myocardial dysfunction in obese spontaneously hypertensive rats,” Journal of Translational Medicine, vol. 10, no. 1, article no. 187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. A. Oliveira-Junior, P. F. Martinez, D. M. Guizoni et al., “AT1 receptor blockade attenuates insulin resistance and myocardial remodeling in rats with diet-induced obesity,” PLoS ONE, vol. 9, no. 1, Article ID e86447, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Larsen, J. Nielsen, C. N. Hansen et al., “Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects,” The Journal of Physiology, vol. 590, no. 14, pp. 3349–3360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Kato, S. Niizuma, Y. Inuzuka et al., “Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure,” Circulation: Heart Failure, vol. 3, no. 3, pp. 420–430, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Mori, L. Zhang, G. Y. Oudit, and G. D. Lopaschuk, “Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure,” Journal of Molecular and Cellular Cardiology, vol. 63, pp. 98–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. M. S. Dodd, D. R. Ball, M. A. Schroeder et al., “In vivo alterations in cardiac metabolism and function in the spontaneously hypertensive rat heart,” Cardiovascular Research, vol. 95, no. 1, pp. 69–76, 2012. View at Publisher · View at Google Scholar · View at Scopus